Description
CNP-TPT, or Topotecan encapsulated in Carbon Nano Particles, is a cutting-edge drug delivery system designed to enhance the effectiveness of topotecan, a chemotherapeutic agent. Encapsulation within carbon nanoparticles improves the stability, bioavailability, and targeted delivery of the drug to cancerous cells. This nanocarrier system aims to reduce systemic toxicity while maximizing therapeutic efficacy, making CNP-TPT a promising solution for advanced cancer treatments. The controlled release properties of the formulation offer potential benefits in improving patient outcomes in oncology
